UroGen Pharma Ltd. (URGN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$19.16
Day's range
$21.06

UroGen Pharma Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RTW INVESTMENTS, LP 08/14/2026 4.54 M $167.22 M   0.00% 9.02%
BLACKROCK, INC. 08/07/2026 3.20 M $117.81 M   12.51% 6.35%
MORGAN STANLEY 08/13/2026 2.58 M $94.81 M   0.64% 5.11%
KYNAM CAPITAL MANAGEMENT, LP 08/14/2026 2.43 M $89.58 M   8.31% 4.83%
JEFFERIES FINANCIAL GROUP INC. 08/17/2026 2.20 M $80.95 M   0.00% 4.37%
SG AMERICAS SECURITIES, LLC 08/07/2026 2.05 M $75.55 M   23.83% 4.07%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.69 M $62.03 M   2.94% 3.35%
ACORN CAPITAL ADVISORS, LLC 08/14/2026 1.67 M $61.58 M   0.00% 3.32%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 1.53 M $56.14 M   100.00% 3.03%
FRONTIER CAPITAL MANAGEMENT CO LLC 08/14/2026 1.51 M $55.51 M   14.80% 2.99%
OPALEYE MANAGEMENT INC. 08/14/2026 1.44 M $52.99 M   0.70% 2.86%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 1.30 M $47.91 M   -13.38% 2.58%
MENORA MIVTACHIM HOLDINGS LTD. 08/13/2026 1.15 M $42.41 M   0.00% 2.29%
D. E. SHAW & CO., INC. 08/14/2026 1.15 M $42.17 M   11.99% 2.27%
STATE STREET CORP 09/22/2026 1.00 M $36.91 M   14.74% 1.99%
MPM BIOIMPACT LLC 08/14/2026 933.42 K $34.35 M   -1.10% 1.85%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 829.81 K $30.54 M   14.14% 1.65%
GOLDMAN SACHS GROUP INC 08/14/2026 819.83 K $30.17 M   36.98% 1.63%
MIGDAL INSURANCE & FINANCIAL HOLDINGS LTD. 08/10/2026 770.91 K $28.37 M   0.00% 1.53%
ORBIMED ADVISORS LLC 08/14/2026 676.19 K $24.88 M   -22.76% 1.34%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 610.36 K $22.46 M   16.52% 1.21%
WOODLINE PARTNERS LP 08/14/2026 500.73 K $18.43 M   0.00% 0.99%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 500.00 K $18.40 M   0.00% 0.99%
BANK OF AMERICA CORP /DE/ 08/14/2026 475.70 K $17.51 M   275.21% 0.94%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 456.56 K $16.80 M   11.48% 0.91%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 08/13/2026 387.07 K $14.24 M   0.00% 0.77%
NORTHERN TRUST CORP 08/13/2026 304.57 K $11.21 M   10.38% 0.60%
RICE HALL JAMES & ASSOCIATES, LLC 08/07/2026 300.65 K $11.06 M   5.18% 0.60%
HENNION & WALSH ASSET MANAGEMENT, INC. 07/08/2026 276.70 K $10.18 M   50.78% 0.55%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 252.40 K $9.29 M   -36.18% 0.50%
J. GOLDMAN & CO LP 08/14/2026 212.78 K $7.83 M   -77.34% 0.42%
PRIVIUM FUND MANAGEMENT B.V. 08/07/2026 210.00 K $7.73 M   -11.81% 0.42%
FMR LLC 08/13/2026 197.10 K $7.25 M   35.97% 0.39%
SUPERSTRING CAPITAL MANAGEMENT LP 08/14/2026 191.31 K $7.04 M   -50.61% 0.38%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2026 174.06 K $6.41 M   -36.70% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 150.30 K $5.53 M   27.37% 0.30%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 149.23 K $5.49 M   3.59% 0.30%
TWO SIGMA INVESTMENTS, LP 08/14/2026 148.96 K $5.48 M   -16.27% 0.30%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 128.37 K $4.72 M   45.11% 0.25%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 128.37 K $4.72 M   100.00% 0.25%
UBS GROUP AG 08/13/2026 121.46 K $4.47 M   -23.92% 0.24%
ELMIND CAPITAL, LP 08/14/2026 120.00 K $4.42 M   -45.45% 0.24%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 115.36 K $4.25 M   15.11% 0.23%
BANK OF NEW YORK MELLON CORP 08/06/2026 113.03 K $4.16 M   14.24% 0.22%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 08/14/2026 111.14 K $4.09 M   -51.81% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 111.00 K $4.08 M   -4.15% 0.22%
AISLING CAPITAL MANAGEMENT LP 08/13/2026 108.00 K $3.97 M   0.00% 0.21%
MILLENNIUM MANAGEMENT LLC 08/14/2026 106.69 K $3.93 M   -71.23% 0.21%
TIDAL INVESTMENTS LLC 08/13/2026 101.84 K $3.75 M   -1.08% 0.20%
ARK INVESTMENT MANAGEMENT LLC 08/14/2026 101.51 K $3.74 M   -12.15% 0.20%

UroGen Pharma Ltd institutional Ownership - FAQ's

During the previous two years, 226 institutional investors and hedge funds held shares of UroGen Pharma Ltd. The most heavily invested institutionals were:

Privium Fund Management B.V.: 107,915

OAK RIDGE INVESTMENTS LLC: 74,743

TRUIST FINANCIAL CORP: 72,303

CITIGROUP INC: 17,973

CenterBook Partners LP: 15,800

Creative Planning: 14,714

84.47% of UroGen Pharma Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 50.17 M shares in the last 24 months. This purchase volume represents approximately $998.91 M in transactions.